Medicare Drug Coverage And Moral Hazard
- 1 January 2004
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 23 (1) , 113-122
- https://doi.org/10.1377/hlthaff.23.1.113
Abstract
This paper explores the effect of more extensive drug coverage in Medicare on the use of and spending for prescription drugs and considers whether any additional use is likely to represent satisfaction of previously unmet needs or whether it represents yet more overuse. Reasonable estimates of the effect on spending strongly suggest that the spending increase will be small and that some of it will go to beneficiaries who do not face high financial barriers at present. Thus, from the viewpoint of improvements in health, national spending on drugs, or pharmaceutical firm revenues, effects are small. The effects of such programs on Medicare’s fiscal future are much more important.Keywords
This publication has 11 references indexed in Scilit:
- Effect of Tiered Prescription Copayments on the Use of Preferred Brand MedicationsMedical Care, 2003
- Employer Drug Benefit Plans and Spending on Prescription DrugsJAMA, 2002
- Are The Benefits Of Newer Drugs Worth Their Cost? Evidence From The 1996 MEPSHealth Affairs, 2001
- Insurance And New Technology: From Hospital To DrugstoreHealth Affairs, 2001
- Insurance Coverage for Prescription DrugsMedical Care, 1999
- Financial Incentives And Drug Spending In Managed CareHealth Affairs, 1999
- The importance of the physician in the generic versus trade-name prescription decision.The RAND Journal of Economics, 1998
- Insurance Choice and the Demand for Prescription DrugsSouthern Economic Journal, 1995
- Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with SchizophreniaNew England Journal of Medicine, 1994
- Payment Restrictions for Prescription Drugs under MedicaidNew England Journal of Medicine, 1987